Merck Partners with Opentrons Labworks, Inc., supporting Lab of the Future
Merck, a leading science and technology company, and Opentrons Labworks, Inc., a leader in lab automation and accessible robotics, announced a multi-year agreement to automate assay kits on a custom Opentrons Flex® workstation.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250123723506/en/
Custom Opentrons Flex® workstation available mid-2025 (Photo: Business Wire)
Scientists and engineers will collaborate to develop and verify platform workflows utilizing Merck’s broad offering of automation-enabled assays. Together, the custom workstation and automation-enabled assays will deliver increased consistency and higher throughput by reducing manual processing and repetitive tasks with a user-friendly robotic system.
“Our customers are prioritizing tools and technologies that improve reproducibility and productivity, allowing them to focus on more complex tasks that take their science further, faster,” said Jean-Charles Wirth, Head of Science & Lab Solutions for the Life Science business of Merck. “Our partnership with Opentrons reinforces our focus to automate and digitalize the lab - supporting scientists at all stages with tools that can increase efficiency, safety, and success rates of delivering new potential therapeutics.”
Customers can place orders for workstations and assay kits from Merck starting mid-2025. Applications will include broad workflows across protein sample preparation, molecular, cell, and other biochemical and chemistry workflows launching throughout the length of the agreement.
“Part of our commitment to making lab automation as accessible as possible is finding partners who share a similar vision,” said Jonathan Brennan-Badal, CEO of Opentrons. “Merck Life Science is a proven leader in terms of the breadth and quality of products they offer for pharmaceutical development and manufacturing, and we’re excited to combine that with our ability to provide world-class automation, service and support.”
By combining the automation expertise and service excellence of Opentrons with the powerful R&D, supply chain, and quality systems of Merck we will deliver reliable products streamlining research from sample prep to analysis for immunodetection, protein research, enzyme technology, genome editing, omics research, pharmaceutical development, service and testing and cell culture.
This adds to Merck’s existing Biology innovations to increase Life Science lab productivity, like the Millicell® DCI Digital Cell Imager that allows for accelerated cell culture analysis with an intuitive interface while also adding to the company’s commitment to provide next-generation biology solutions such as their recent acquisition of HUB Organoids Holding B.V.
About Merck
Merck, a leading science and technology company, operates across life science, healthcare and electronics. Around 63,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From providing products and services that accelerate drug development and manufacturing as well as discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2023, Merck generated sales of € 21 billion in 65 countries.
Scientific exploration and responsible entrepreneurship have been key to Merck’s technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the business sectors of Merck operate as MilliporeSigma in life science, EMD Serono in healthcare, and EMD Electronics in electronics.
About Opentrons
Opentrons Labworks, Inc., a disruptive life science company and the current market leader in entry-level lab automation, accelerates innovation in research and healthcare through its integrated lab platform, which includes business units Opentrons® Robotics and Neochromosome™. Opentrons has raised over $200 million in funding and achieved unicorn status based on its innovative technologies. The Opentrons Flex® is Opentrons’ newest generation of liquid-handling lab robots, offering open-source accessibility and compatibility with generative AI tools. Opentrons Robotics provides thousands of institutions with flexible, easy-to-use lab robots, automating R&D operations and making robotics, a vast open-source library accessible to life sciences researchers worldwide. Opentrons is used in labs at the top 20 academic universities in the US and 14 of 15 leading global biopharmaceutical companies. Learn more at https://opentrons.com/.
All Merck press releases are distributed by e-mail at the same time they become available on the Merck website. Please go to www.merckgroup.com/subscribe to register online, change your selection or discontinue this service.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250123723506/en/
Contacts
Media Relations
rachel.bloom-baglin@merckgroup.com
Phone: +49 (6151) 72-44461
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SES Announces Completion of €100m Open Market Repurchase of its NC625 Securities23.1.2025 18:58:00 CET | Press Release
SES S.A. announces it has repurchased in the open market an aggregate amount of €99,978,000 principal amount of its €625,000,000 Deeply Subordinated Fixed Rate Resettable Securities issued on 27 May 2021. In accordance with the terms and conditions of the Securities, the purchased Securities will be cancelled. Following these transactions, the outstanding principal amount of the Securities is €525,022,000. Payment in relation to the Securities will be made in accordance with the usual procedures of Clearstream, Luxembourg and/or Euroclear. The success of these transactions reduces SES's outstanding debt obligation, demonstrating SES’s financial flexibility and its strong cash-generation profile. SES may seek to make further repurchases of its Securities from time to time, subject to market conditions. This announcement does not constitute or form part of an offer to sell or purchase, or a solicitation of an offer to sell or purchase the Securities or any other securities. Follow us on:
Andersen Global Grows Argentine Presence with Collaborating Firm Confis23.1.2025 15:30:00 CET | Press Release
Andersen Global expands its presence in Argentina through a Collaboration Agreement with Confis, a tax firm based in Córdoba serving clients throughout the country and region. Andersen currently has a presence in Buenos Aires led by Managing Partner Cecilia Goldemberg. “We’ve been very fortunate to work with teams like Confis whose services and culture complement our own as well as they do,” shared Cecilia. “Our clients and people are already seeing the benefits.” Founded in 1997, Confis is a trusted advisor for companies operating in both domestic and international markets. The firm offers a wide range of services, including tax review and management, corporate finance, fiscal and labor advisory, payroll management, risk management, and startup support. “Córdoba's strategic position as an industrial and technological hub underscores the importance of delivering tailored local expertise and providing comprehensive tax and financial solutions,” Founding Partner Fernando Nestor said. “By
InMotion Ventures Invests $2 Million in Cyclic Materials, Extending Series B to $55 Million23.1.2025 15:00:00 CET | Press Release
Cyclic Materials, the advanced recycling company building a circular supply chain for Rare Earth Elements and other critical materials, today announced a $2 million investment from InMotion Ventures, the investment arm of Jaguar Land Rover (JLR). This latest backing lifts the company’s Series B round to $55 million, underscoring its critical role in advancing sustainable supply chains for the automotive industry and beyond. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250123234060/en/ Cyclic Materials extracts REEs from various end-of-life products, including EVs, consumer electronics, and medical equipment. Pictured are recycled EV and hybrid vehicle motors. (Photo: Business Wire) Rare Earth Elements (REEs) are an essential component in permanent magnets, which are found in everything from data centers and wind turbines to cell phones, electric vehicles, and power tools. Despite their significance, less than 1% of REEs ar
Technology Holdings to Rebrand as TH Global Capital and Expand into Asset Management and Growth Advisory23.1.2025 14:56:00 CET | Press Release
Technology Holdings, an award-winning global investment banking firm with operations in 13 countries across 5 continents including the Americas, Europe, and Asia-Pacific, announced that it will be rebranding to TH Global Capital. This rebrand reflects the firm’s continued expansion into additional sectors and products including Asset Management and an expanded Growth Advisory offering to create wealth for its clients. TH Global Capital, is designed to reflect the firm’s comprehensive offering, including Sell Side M&A, its Buy Side M&A practice 'TH Buy and Build', Growth Equity, Debt Financing, Financial Sponsor Coverage & Secondaries, IPO Advisory, Asset Management and Growth Advisory services. This includes the launch of TH Global Asset Management and an expanded growth advisory services offering, aimed at helping companies protect and grow their valuations through focused growth strategy advice. The firm also announced it's now becoming a purpose-driven company, with a singular purpo
SLB Capturi powers up its first modular carbon capture plant23.1.2025 14:26:00 CET | Press Release
Global energy technology companySLB (NYSE: SLB) announced today that SLB Capturi has completed commissioning and is handing over its modular carbon capture plant at Twence’s waste-to-energy facility in Hengelo, Netherlands. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250123296222/en/ The new plant has the capacity to capture up to 100,000 metric tons of CO2 per year, which will be used in applications for the horticulture and food and beverage sectors. (Photo: Business Wire) The new plant has the capacity to capture up to 100,000 metric tons of CO2 per year, which will be used in applications for the horticulture and food and beverage sectors. The carbon capture plant is based on SLB Capturi’s standard, modular Just Catch™ design, which reduces onsite installation and outfitting work — providing a more cost-efficient and easier-to-deploy option compared with other market alternatives. “We are extremely proud of our collab
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom